News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Spermatech Licenses Dotmatics' Platform to Support Their Male Contraceptive Research



10/30/2012 7:22:25 AM

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics Limited, a leading supplier of scientific informatics solutions to the Biotech industry, announced today that Spermatech AS, an early drug discovery company based in Oslo, has selected the Dotmatics Platform as their central system to manage and analyse their scientific data.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES